Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT07141316
Active, not recruiting Not applicable

Effects of Blood Flow Restriction Combined With Electrostimulation After Knee Arthroplasty

NCT07141316 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Pavia
Phase
Not applicable
Started
2025-07-10
Last updated
2025-08-26

Condition(s) studied

Osteo Arthritis Knee

Investigational drug(s) / intervention(s)

Blood flow restriction combined with electrostimulation.

Blood flow restriction combined with electrostimulation.: Participants will perform 30 minutes of blood flow restriction once a day during electrostimulation of the quadriceps of the operated limb.

Study summary

The goal of this clinical trial is to learn whether blood flow restriction (BFR) combined with electrostimulation (ES) can improve the postoperative course of patients undergoing total knee arthroplasty. The main questions it aims to answer are:

Immediately after surgery, do BFR combined with ES increase quadriceps strength? Do they also improve the functional abilities of patients? Researchers will compare BFR combined with ES to ES alone, to see if there are differences.

Participants will carry out a daily session of BFR+ ES or ES alone for six working days after surgery

Eligibility

Sex
ALL
Min age
60 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * Elective knee arthroplasty surgery Exclusion Criteria: * obesity (body mass index equal to or greater than 30 Kg/m2); * concomitant orthopaedic or neurological pathologies (other than the pathology for which arthroprosthesis has been indicated) that modify walking capacity; * pathologies that modify the balance (neurological and/or vestibular); * contraindications to the use of medical equipment used in the practice; * inability to understand and sign informed consent.

Primary outcome measure(s)

  • Maximum quadriceps strength of the operated limb — From the second to the tenth day post surgery.
    Maximum quadriceps strength, measured with a dynamometer and expressed in kilograms

Trial sites (1)

FacilityCityRegionStatus
Istituto di Cura "Città di Pavia" Pavia Italy

More University of Pavia trials in Italy

Efficacy of Transverse Maxillary Expansion With AMCOP Preformed Appliances Enrolling by invitation
Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging Starting soon
Comparison of Digital Analysis and Artificial Intelligence for Cephalometric Tracing Recruiting
Adjunctive Periodontal Treatment With Coenzyme Q10 in Association With Probiotics for Pregnant Women Enrolling by invitation
Clinical and Functional Outcomes After Subtalar Arthroereisis in Pediatric Flexible Flatfoot Active, not recruiting

Other trials for the same condition

Persistent Pain in Pharmacologically or Surgical Treated Osteoarthritis: Role of Mu-Limpho Marker Recruiting
Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07141316 on ClinicalTrials.gov ↗ ← All trials in Italy